Las infecciones por VIH entre usuarios de drogas inyectables se han reducido a la mitad en la última década en Estados Unidos, pasando del 18% de 1990 al 9% de la actualidad. La mala noticia es que se ha reducido también el empleo del test del VIH, a pesar de conductas de riesgo como el uso compartido de jeringuillas. Más
- Primary Tuberculosis of the Pharynx in an HIV Context: A Case Report 07/05/2024
- The Social Construction of Aging Among a Clinic-Based Population and Their Healthcare Workers in Zambia 07/05/2024
- Time to Treatment Failure and Its Predictors Among Second-Line ART Clients in Amhara Region, Ethiopia: A Retrospective Follow-Up Study 07/05/2024
- HIV-1 transmission dynamics among people who inject drugs on the US/Mexico border during the COVID-19 pandemic: a prosepective cohort study 07/05/2024
- SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice 07/05/2024
 |
 |
 |
 |
- DDT pollutants found in deep sea fish off Los Angeles coast 06/05/2024
- Past and guides future efforts to reduce cancer disparities 06/05/2024
- Simulated chemistry: New AI platform designs tomorrow's cancer drugs 06/05/2024
- Expanding a lymph node, boosting a vaccine 06/05/2024
- Self-critical perfectionism gnaws on students' well-being already in lower secondary school 06/05/2024
 |
7 de mayo de 2024
| Sitio presentado el 18 de mayo de 2010 |  |
DE NUESTROS LECTORES